St. Jude wins European OK for brain implant to treat Dystonia
April 10 (Reuters) - St. Jude Medical Inc on Wednesday said it received European regulatory approval for its brain implant used to treat primary and secondary Dystonia, a neurological movement disorder.
The maker of heart pacemakers, valves and other medical devices said European regulators approved its Brio, Kibra and LibraXP deep brain stimulation systems for managing symptoms of the incurable disease.
Dystonia causes a person's muscles to involuntarily contract and spasm, and can leave its victims wheelchair-bound.
- Total CEO de Margerie killed in Moscow as jet hits snow plow |
- Sweden gets two new sightings, as hunt for undersea intruder goes on
- Pistorius starts five-year term for killing Reeva Steenkamp
- U.S. to funnel travelers from Ebola-hit region through five airports
- Ebola crisis turns a corner as U.S. issues new treatment protocols